Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Malin founder withdraws claims for conversion of 787,000 shares

Wed, 17th Aug 2022 12:30

(Alliance News) - Malin Corp PLC on Wednesday said one of its founders Crow Rock Capital Ltd has withdrawn its legal claim against the company and surrendered its A shares to Malin.

Back in October, Malin said it had received and rejected a notice to convert A shares into a 6.2% stake of ordinary shares. Conversion notice was received from its founders, who are members of a Brandon Point Industries group company.

The conversion notice was for 2.9 million A shares, 88% of the 3.3 million issued to the founders. Malin said the founders claimed that the EUR68.1 million sale of Malin's 65% stake in Altan Pharma, completed at the start of this month, constitutes a change of control event, allowing the conversion.

Following this, the founders initiated court proceedings against Malin at the Irish High Court, claiming an entitlement to the conversion of their A shares.

On Wednesday, Malin confirmed that one of the founders Crow Rock Capital, which holds 787,032 A shares, has withdrawn its claim against Malin and surrendered its shares to the company.

Malin added that it continues to reject the conversion notice, "on the basis that no change of control has occurred and the conversion rights carried by A ordinary shares are not currently exercisable".

"The board will take all necessary steps to vigorously defend the company and shareholders against the remaining founders' claims in the proceedings," Malin Corp said.

Malin shares were untraded at EUR4.99 each in Dublin on Wednesday around midday.

By Sophie Rose; sophierose@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.


Shares in this article

Related News

EARNINGS AND TRADING: Connecting Excellence hails record January fees
26 Feb 2026

EARNINGS AND TRADING: Connecting Excellence hails record January fees

(Alliance News) - The following is a round-up of earnings and trading updates for London-listed companies, issued on Thursday and not separately repor...

Malin in valuation fall amid Poseida sale, EUR150 million return
27 Aug 2025

Malin in valuation fall amid Poseida sale, EUR150 million return

(Alliance News) - Malin Corp PLC on Wednesday reported a valuation decline over the first half of 2025, but hailed the sale of its Poseida Therapeutic...